Locations:
Search
Findings promise to shape future antiplatelet drug development and treatment strategies
Robust signal from observational study raises prospect of a long-sought medical therapy
LLM-driven system uses both structured and unstructured data, provides auditable justifications
CD36 loss-of-function variant accounts for large portion of risk in this population
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
First-in-human phase 1 trial induced loss of function in gene that codes for ANGPTL3
Blood test can identify patients who need more frequent monitoring or earlier surgery to prevent dissection or rupture
Phase 3 TANDEM study may help pave way to first approval of a CETP inhibitor
5% of flagged ECGs in real-world study were from patients with previously undiagnosed HCM
Metabolites from animal product substrates implicated in heart failure development in community cohorts
Study authors urge reevaluation of the sweetener’s safety designation by food regulators
Advertisement
Advertisement